ArticleCureus2025
Keratoacanthoma-Type Invasive Squamous Cell Carcinoma Managed Non-surgically With Topical Immunomodulators.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A rapidly growing lesion with keratoacanthoma-like features may complicate early diagnosis of squamous cell carcinoma (SCC). While most cutaneous SCCs exhibit slow, indolent growth, lesions with keratoacanthoma-like features may demonstrate more rapid expansion, occasionally complicating early diagnosis. We report a case of a 71-year-old male patient with a history of actinic keratoses and non-melanoma skin cancer who presented with a new blistering, erythematous eruption on the left dorsal forearm. A potassium hydroxide (KOH) prep revealed branching hyphae, and the patient was initially treated with oral antifungals. However, biopsy of the lesion confirmed a well-differentiated invasive SCC of keratoacanthoma type. Given the lesion's size and clinical behavior, the patient was referred for oncology-directed care and successfully treated with topical immunomodulation. PET imaging ruled out metastasis, and clinical resolution was observed on follow-up. This case underscores the diagnostic complexity of keratoacanthoma-like SCCs and highlights the need for biopsy in suspicious or atypical presentations. It also reflects evolving treatment approaches in select cases of cutaneous SCC, particularly among elderly patients with comorbidities or those who decline surgical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.